Successful treatment of occult pancreatic melanoma using BRAF/MEK inhibitors.

J Dermatol　47,P.e126-e147　/　2020

Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and L-arginine after DNA analysis produced a definitive diagnosis

Clin J Gastroenterol　13,P.823-833　/　2020

Cytomegalovirus enterocolitis in a patient with refractory immune-related colitis.

Case Rep Gastroenterol　14,P.103-109　/　2020

Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy

J Clin Exp Hematop　60,P.51-54　/　2020

Multiple Gastric Polyps Improved After Treatment for Ulcerative Colitis.

Inflamm Bowel Dis　26,P.e144-e145　/　2020

Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer

Intern Med　59,P.2499-2504　/　2020

Complete Removal of Adrenal Metastasis in Hepatocellular Carcinoma Using Indocyanine Green Fluorescent Imaging.

Anticancer Res　40,P.5823-5828　/　2020

Hepatocellular Carcinoma With Extensive Cancer-associated Thrombosis Successfully Treated With Liver Resection and Direct Oral Anticoagulant: A Case Report.

Anticancer Res　40,P.6465-6471　/　2020

Cholangiolocarcinoma With Multiple Recurrences Successfully Treated With Repeated Liver Resection and Radiofrequency Ablation.

Anticancer Res　40,P.7147-7153　/　2020

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

Hepatol Int　14,P.1023-1033　/　2020

Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study.

BMC Gastroenterol　20,P.371　/　2020

Prostaglandin E2-EP4 Axis Promotes Lipolysis and Fibrosis in Adipose Tissue Leading to Ectopic Fat Deposition and Insulin Resistance.

Cell Rep　33,P.108265　/　2020

Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA

Virus Res　290,P.198191　/　2020

Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture

Int. J. Mol. Sci　21,P.7251　/　2020

Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups.

Pancreatology　20,P.1421-1427　/　2020

Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virus

Hepatol Res　50,P.1128-1140　/　2020

Hepatitis B surface antigen, core-related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation.

Liver Int　40,P.2961-2971　/　2020

Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis

Dig Dis Sci.　66,P.1080-1089　/　2020

Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy

Liver Cancer　9,P.207-220　/　2020

The metabolite, alpha-ketoglutarate inhibits non-alcoholic fatty liver disease progression by targeting lipid metabolism

Liver Research　9,P.94-100　/　2020

"Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma"

J Hepatol　73,P.285-293　/　2020

Fluorescence-based biochemical analysis of human hepatitis B virus reverse transcriptase activity

Anal Biochem　597,P.113642　/　2020

Melinjo seed extract increases adiponectin multimerization in physiological and pathological conditions.

Sci Rep　10,P.4313　/　2020

Prometastatic Secretome Trafficking via Exosomes Initiates Pancreatic Cancer Pulmonary Metastasis.

Cancer Lett　481,P.63-75　/　2020

The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world:

Hepatol Int　14,P.225-238　/　2020

A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population.

Diabetes Metab Syndr Obes　13,P.333-341　/　2020

7-Deaza-7-fluoro modification confers on 4'-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety

Antiviral Res　176,P.104744　/　2020

JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study.

J Gastroenterol　55,P.640-652　/　2020

Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling.

Hepatol Commun　4,P.255-267　/　2020

Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.

J Gastroenterol Hepatol　35,P.1420-1425　/　2020

MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.

Cancer Sci　111,P.869-880　/　2020

Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer.

Carcinogenesis　41,P.1145-1157　/　2020

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication.

Clin Infect Dis　71,P.2840-2848　/　2020

Comparison of a 22-gauge Franseen-tip needle with a 20-gauge forward-bevel needle for the diagnosis of type 1 autoimmune pancreatitis: a prospective, randomized, controlled, multicenter study (COMPAS study).

Gastrointest Endosc　91,P.373-381.e2.　/　2020

Tenofovir versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

Am J Gastroenterol　115,P.271-280　/　2020

Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West.

Hepatology　71,P.1910-1922　/　2020

Real-world experience of 12-week DAA regimen of glecaprevir and pibrentasvir in patients with chronic HCV infection.

J Gastroenterol Hepatol　35,P.855-861　/　2020

Risk stratification of advanced colorectal neoplasia after baseline colonoscopy: Cohort study of 17 Japanese community practices.

Dig Endosc　32,P.106-113　/　2020

Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett’s esophagus

J Gastroenterol Hepatol　35,P.211-217　/　2020

あなたの肝臓は大丈夫？　

朝日新聞　12/26掲載,　/　2020

「肝硬変や肝がん」を予防するために.　

朝日新聞　12/23掲載,　/　2020

恩師をたたえ「道を開いた人」熊大・田中教授、医学生理学賞オルター氏と交流

熊本日日新聞　10/7掲載,　/　2020

日本人に最も多い肝臓病　ウイルス性肝炎の治療と予防法

読売新聞　7/30掲載,　/　2020

「膵臓がん」

西日本新聞　/　2020

空気、意識してますか？

私の内視鏡Tips　/　2020

直腸病変の診断は要注意！

私の内視鏡Tips　/　2020

「胆膵内視鏡とYコネクター」

私の内視鏡Tips　/　2020

遺伝・ゲノム学　C型肝炎治療後の肝発癌とTLL1遺伝子多型

医学のあゆみ　274,P.359-360　/　2020

【ウイルス肝炎の最新動向】B型肝炎の病態・検査に関する最近の話題

日本医師会雑誌　148,P.2155-2159　/　2020

「全身疾患と排便障害　肝疾患」

臨床と研究　96,P.1289-1292　/　2020

【ウイルス感染と血液疾患】B型肝炎ウイルスによる発がん機構

血液内科　81,P.659-665　/　2020

【ここがキモ!いまはこうする　肝疾患vs.薬物療法　肝機能評価&薬物性肝障害マネジメントに強くなる】(第5章)薬物性肝障害(DILI)へのアプローチ　薬物におけるB型肝炎ウイルス(HBV)再活性化の現状と方策

月間薬事　62,P.368-376　/　2020

【教えて! 健診/検診ホントのところ"-エビデンスを知り,何を伝えるか】特定の疾病を見つけるための検診　肝炎ウイルス検診　HBs抗原検査,HCV抗体検査"

Medicina　57,P.932-936　/　2020

C型肝炎ウイルス感染によるDysbiosis(腸内フローラ異常)と病態進展へのインパクト

Nagoya Medical Journal　56,P.273-278　/　2020

【B型肝炎Trends & Topics】B型肝炎ウイルスの感染・複製機構　なぜHBV排除は困難なのか

臨床消化器内科　35,P.137-145　/　2020

"（薬剤性消化器疾患の治療(3)肝臓） 薬剤性消化器疾患の治療"

臨床消化器内科　35,P.733-740　/　2020

【B型肝炎診療の現在】B型肝炎に対する新規薬剤の開発状況

消化器・肝臓内科　8,P.197-204　/　2020